PPCB

Propanc Biopharma (PK) (PPCB)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:PPCB
DataOraFonteTitoloSimboloCompagnia
15/05/202322:19Edgar (US Regulatory)Quarterly Report (10-q)USOTC:PPCBPropanc Biopharma Inc (PK)
15/05/202322:09Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PPCBPropanc Biopharma Inc (PK)
04/04/202317:23Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:PPCBPropanc Biopharma Inc (PK)
28/03/202312:04Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:PPCBPropanc Biopharma Inc (PK)
24/03/202321:05Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:PPCBPropanc Biopharma Inc (PK)
23/09/202216:56Edgar (US Regulatory)Proxy Statement - Other Information (preliminary) (pre 14c)USOTC:PPCBPropanc Biopharma Inc (PK)
22/06/202220:10AllPennyStocks.comSometimes All It Takes Is A MentionUSOTC:PPCBPropanc Biopharma Inc (PK)
22/03/202219:25AllPennyStocks.comUSPTO Notice Of Allowance Sends Micro Cap SoaringUSOTC:PPCBPropanc Biopharma Inc (PK)
03/02/202222:23Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:PPCBPropanc Biopharma Inc (PK)
08/09/202123:02Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:PPCBPropanc Biopharma Inc (PK)
20/08/202112:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:PPCBPropanc Biopharma Inc (PK)
20/08/202112:15Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:PPCBPropanc Biopharma Inc (PK)
03/11/202023:09Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:PPCBPropanc Biopharma Inc (PK)
01/10/202023:32Edgar (US Regulatory)Annual Report (10-k)USOTC:PPCBPropanc Biopharma Inc (PK)
28/07/202014:26InvestorsHub NewsWireALYI Signals BUY After African Electric Vehicle ConfirmationUSOTC:PPCBPropanc Biopharma Inc (PK)
22/07/202017:40Edgar (US Regulatory)Information Statements (revised) (prer14c)USOTC:PPCBPropanc Biopharma Inc (PK)
17/04/202022:16Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:PPCBPropanc Biopharma Inc (PK)
19/02/202012:01Edgar (US Regulatory)Information Statement - All Other (definitive) (def 14c)USOTC:PPCBPropanc Biopharma Inc (PK)
30/09/201920:28Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:PPCBPropanc Biopharma Inc (PK)
21/08/201922:32Edgar (US Regulatory)Withdrawal of Registration Statement (rw)USOTC:PPCBPropanc Biopharma Inc (PK)
20/08/201923:30Edgar (US Regulatory)Withdrawal of a Registration Statement Withdrawal Request (rw Wd)USOTC:PPCBPropanc Biopharma Inc (PK)
30/05/201919:40InvestorsHub NewsWireUnder the Radar Biotechs To Research NowUSOTC:PPCBPropanc Biopharma Inc (PK)
17/05/201914:00InvestorsHub NewsWireBiotech Stock Closing in on Human TrialsUSOTC:PPCBPropanc Biopharma Inc (PK)
18/04/201714:45InvestorWirePositive News in the Fight against Cancer Fuels Quest for More Good TidingsUSOTC:PPCBPropanc Biopharma Inc (PK)
08/08/201613:20InvestorsHub NewsWireFriendable, Inc. (OTC Pink: FDBL) – User Growth & Time Spent in App Up – Invests in Infrastructure & TechnologyUSOTC:PPCBPropanc Biopharma Inc (PK)
30/11/201514:30Access WirePropanc Receives Additional $700,000 After Successful Completion of Animal Efficacy StudiesUSOTC:PPCBPropanc Biopharma Inc (PK)
17/11/201514:30Access WirePropanc Demonstrates Significant Anti-Tumor Efficacy in Pancreatic and Ovarian Cancer Preclinical Models; Files Patent Specif...USOTC:PPCBPropanc Biopharma Inc (PK)
26/10/201517:10Access WirePropanc Selected by OTC Markets Group to Join the OTCQB Venture IndexUSOTC:PPCBPropanc Biopharma Inc (PK)
01/10/201514:00Access WirePropanc Secures Financing to Complete Preclinical Animal Studies and Progress Company towards Human Trials; Updates on Progre...USOTC:PPCBPropanc Biopharma Inc (PK)
31/08/201514:45Access WirePropanc Receives Patent Approval in Key JurisdictionUSOTC:PPCBPropanc Biopharma Inc (PK)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:PPCB
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network